Moleculin Biotech, Inc. (MBRX)
Moleculin Biotech, Inc. is a clinical-stage pharmaceutical company dedicated to advancing therapeutic candidates designed to combat highly aggressive cancers and viral infections. Their primary investigational drug, Annamycin, is currently undergoing Phase 1/2 clinical trials. These trials aim to assess its efficacy against acute myeloid leukemia (AML) that has relapsed or is resistant to prior therapies, as well as malignancies that have spread to the lungs. WP1066, a prominent immune/transcription modulator for the company, is presently in Phase I studies, targeting both adult and pediatric brain tumors, pancreatic cancer, and other types of aggressive malignancies. Further, the firm is developing WP1220, an analog of WP1066, intended for topical application in treating cutaneous T-cell lymphoma. Another compound, WP1122, is under development for glioblastoma multiforme and COVID-19. Moleculin Biotech has established collaboration agreements and partnerships with organizations such as MD Anderson, Animal Life Sciences, LLC, and WPD Pharmaceuticals Sp z.o.o. The company was founded in 2015 and maintains its principal offices in Houston, Texas.
Sector: Pharmaceutical Preparations
Industry: Biotechnology
Moleculin Biotech, Inc.
NASDAQ:MBRXHealthcare · Biotechnology
-9.40%$7.90
AH$7.90+0.00%vs close
Mkt Cap-
Float1.02M
O/S-
Vol
$ Vol
RVOL
Inst Own0.9%
Earnings
Dilution
Financials Summary
Revenue$0
Net Income-$33.56M
Total Assets$22.13M
Free Cash Flow-$22.73M
Debt & Equity
Debt 2%
Equity 98%
Total Debt$359K
Total Equity$15.01M
Shares Outstanding
Short Interest
Split History4 splits · 4 reverse
2-year cumulative
1:500Over cap
Past the 1:250 Nasdaq cap, ineligible for a bid-price compliance period
- 1:20Reverse splitOct 20, 202620 shares → 1
- 1:25Reverse splitDec 1, 202525 shares → 1
- 1:15Reverse splitMar 22, 202415 shares → 1
- 1:6Reverse splitFeb 1, 20216 shares → 1
Balance Sheet Details
Assets$22.13M
Liabilities$7.12M
Accounts Receivable$7K
Accounts Payable$3.51M
Inventory$0
PP&E (Net)$314K
Goodwill$0
Intangible Assets$11.15M
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 |
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Revenue | $90K | $0 | $0 | $0 | $0 | $0 | $185K | $68K | $18K | $6K | $0 |
| Gross Profit | -$90K | $0 | $0 | $0 | $0 | $0 | -$185K | -$68K | -$18K | -$6K | $0 |
| Gross Margin | - | - | - | - | - | - | - | - | - | - | - |
| Research and Development | $15.89M | $17.73M | $19.49M | $18.97M | $14.42M | $12.76M | $11.01M | $9.73M | $4.54M | $1.5M | $260K |
| Selling, General, and Administrative | $9.12M | $8.79M | $10.02M | $11.54M | $8.39M | $6.79M | $6.33M | $5.3M | $4.09M | $2.38M | $478K |
| Other | $90K | $126K | $127K | $130K | $164K | $200K | $0 | -$40K | $18K | $6K | $0 |
| Total Operating Expenses | $25.1M | $26.64M | $29.63M | $30.64M | $22.97M | $19.74M | $17.34M | $15.03M | $8.65M | $3.88M | $738K |
| Operating Income (EBIT) | -$25.1M | -$26.64M | -$29.63M | -$30.64M | -$22.97M | -$19.74M | -$17.52M | -$15.03M | -$8.65M | -$3.88M | -$738K |
| Operating Margin | - | - | - | - | - | - | - | - | - | - | - |
| Interest Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $43K | $0 |
| Interest Income | $105K | $550K | $1.37M | $240K | $306K | $13K | $13K | $0 | $0 | $0 | $24K |
| Other Income (Expense) | -$8.46M | $4.88M | -$138K | $1.61M | $7.07M | $2.39M | $4.09M | $3.15M | -$1.15M | -$43K | -$10K |
| Income Before Tax (EBT) | -$33.56M | -$21.76M | -$29.77M | -$29.02M | -$15.89M | -$17.36M | -$13.43M | -$11.88M | -$9.8M | -$3.93M | -$748K |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | -$229K | $0 | $0 | $0 | $0 |
| Net Income | -$33.56M | -$21.76M | -$29.77M | -$29.02M | -$15.89M | -$17.36M | -$13.21M | -$11.88M | -$9.8M | -$3.93M | -$748K |
| Net Income Margin | - | - | - | - | - | - | - | - | - | - | - |
| Supplementary Data | |||||||||||
| EPS | -28.42 | -189.14 | -376.71 | -380.51 | -221.77 | -661.00 | -729.63 | -1031.54 | -1188.07 | -900.00 | -117.97 |
| Diluted EPS | -28.42 | -189.14 | -376.71 | -380.51 | -221.77 | -661.00 | -729.63 | -1031.54 | -1188.07 | -900.00 | -117.97 |
| Weighted Average OS | 1.18M | 137,720 | 79,024 | 76,278 | 71,669 | 26,255 | 18,098 | 11,512 | 8,252 | 4,367 | 6,343 |
| EBITDA | -$33.47M | -$21.64M | -$29.64M | -$28.89M | -$15.73M | -$19.54M | -$13.23M | -$14.96M | -$8.63M | -$3.88M | $0 |
| EBITDA Margin | - | - | - | - | - | - | - | - | - | - | - |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 |
| Assets | |||||||||||
| Current Assets | |||||||||||
| Cash and Cash Equivalents | $8.88M | $4.28M | $23.55M | $43.15M | $70.9M | $15.17M | $10.73M | $7.13M | $7.71M | $5.01M | $28K |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cash and Short-Term Investments | $8.88M | $4.28M | $23.55M | $43.15M | $70.9M | $15.17M | $10.73M | $7.13M | $7.71M | $5.01M | $28K |
| Accounts Receivable | $7K | $0 | $0 | $0 | $45K | $1K | $11K | $56K | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $278K | $351K | $644K | $823K | $486K | $1.45M | $2.39M | $784K | $0 | $0 | $0 |
| Total Current Assets | $9.69M | $5.19M | $26.27M | $45.6M | $72.5M | $17.2M | $13.48M | $7.97M | $8.3M | $5.22M | $28K |
| Long-Term Assets | |||||||||||
| Property, Plant & Equipment Net | $314K | $583K | $796K | $678K | $445K | $685K | $603K | $463K | $33K | $23K | $0 |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $11.15M | $11.15M | $11.15M | $11.15M | $11.15M | $11.15M | $11.15M | $11.15M | $11.15M | $11.15M | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $129K | $0 | $0 | $0 | $0 | $3K |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $978K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$0 |
| Total Long-Term Assets | $12.44M | $11.73M | $11.94M | $11.83M | $11.59M | $11.96M | $11.75M | $11.61M | $11.18M | $11.17M | $3K |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$3K |
| Total Assets | $22.13M | $16.93M | $38.22M | $57.42M | $84.09M | $29.16M | $25.23M | $19.59M | $19.48M | $16.39M | $28K |
| Liabilities | |||||||||||
| Current Liabilities | |||||||||||
| Accounts Payable | $3.51M | $2.03M | $2.5M | $2.1M | $1.36M | $1.13M | $2.15M | $1.25M | $810K | $399K | $0 |
| Short-Term Debt | $137K | $0 | $0 | $0 | $96K | $118K | $103K | $0 | $0 | $296K | $450K |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$399K | -$235K |
| Other Current Liabilities | $1.39M | $0 | $0 | $0 | $1.56M | $1.25M | $878K | $2.29M | $1.16M | $67 | $88K |
| Total Current Liabilities | $6.85M | $5.36M | $6.82M | $4.82M | $3.62M | $2.92M | $3.57M | $3.88M | $2.21M | $1.35M | $773K |
| Long-Term Liabilities | |||||||||||
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $107K | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $44K | $5.23M | $4.86M | $77K | $1.41M | $8.19M | $5.82M | $1.44M | $150K | $88K | $0 |
| Total Long-Term Liabilities | $266K | $5.59M | $5.33M | $412K | $1.48M | $8.35M | $6.09M | $1.44M | $150K | $88K | $450K |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$450K |
| Total Liabilities | $7.12M | $10.95M | $12.14M | $5.23M | $5.1M | $11.27M | $9.66M | $5.31M | $2.37M | $1.43M | $773K |
| Stockholders' Equity | |||||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $3K |
| Common Stock | $3K | $3K | $33K | $29K | $29K | $69K | $46K | $29K | $21K | $12K | $7K |
| Retained Earnings | -$206M | -$153.37M | -$131.6M | -$101.83M | -$72.81M | -$56.92M | -$39.56M | -$26.36M | -$14.48M | -$4.67M | -$748K |
| Comprehensive Income & Other | $10K | -$41K | -$9K | $12K | $41K | $65K | $31K | $35K | -$0 | -$0 | -$3K |
| Other Stockholders' Equity | $221.01M | $159.34M | $157.64M | $154M | $151.77M | $74.74M | $55.09M | $40.6M | $31.58M | $19.62M | -$3K |
| Total Equity | $15.01M | $5.98M | $26.07M | $52.19M | $78.99M | $17.89M | $15.57M | $14.27M | $17.12M | $14.96M | -$745K |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $22.13M | $16.93M | $38.22M | $57.42M | $84.09M | $29.16M | $25.23M | $19.59M | $19.48M | $16.39M | $28K |
| Supplementary Data | |||||||||||
| Total Debt | $359K | $478K | $574K | $451K | $159K | $277K | $379K | $0 | $0 | $296K | $450K |
| Net Debt | -$8.52M | -$3.8M | -$22.98M | -$42.69M | -$70.74M | -$14.9M | -$10.36M | -$7.13M | -$7.71M | -$4.71M | $422K |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 |
| Operating Activities | |||||||||||
| Net Income | -$33.56M | -$21.76M | -$29.77M | -$29.02M | -$15.89M | -$17.36M | -$13.21M | -$11.88M | -$9.8M | -$3.93M | -$748K |
| Depreciation & Amortization | $90K | $126K | $127K | $130K | $164K | $200K | $199K | $68K | $18K | $6K | $1.77M |
| Deferred Income Tax | $0 | $0 | $0 | $0 | -$6.73M | -$2.34M | $0 | $0 | -$1.39M | $0 | $0 |
| Stock-Based Compensation | $1.66M | $1.73M | $1.98M | $2.27M | $2.37M | $1.68M | $1.54M | $1.14M | $707K | $411K | $0 |
| Changes in Working Capital: | |||||||||||
| Accounts Receivable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Accounts Payable | $1.33M | -$468K | $403K | $731K | $235K | -$1.02M | $907K | $436K | $411K | -$41.13M | $0 |
| Other Working Capital | -$775K | $699K | $1.22M | -$507K | $803K | $983K | -$3.05M | $1.17M | $131K | $40.87M | $323K |
| Total Working Capital Change | $555K | $231K | $1.62M | $224K | $1.04M | -$41K | -$2.14M | $1.61M | $542K | -$256K | $323K |
| Other Non-Cash Items | $8.52M | -$4.18M | $1.94M | -$1.24M | $96K | $85K | -$3.59M | -$3.15M | $2.6M | $424K | -$1.77M |
| Net Cash from Operating | -$22.73M | -$23.86M | -$24.1M | -$27.64M | -$18.95M | -$17.77M | -$17.2M | -$12.2M | -$7.32M | -$3.76M | -$424K |
| Investing Activities | |||||||||||
| Capital Expenditures | $0 | -$13K | -$124K | -$67K | -$19K | -$376K | -$52K | -$417K | -$28K | -$21K | $0 |
| Acquisitions | $0 | $0 | $0 | $0 | $0 | $2K | $0 | $0 | $0 | -$100K | $0 |
| Purchases of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Sales of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Investing Activities | $0 | $0 | $0 | $0 | $0 | $0 | $1K | $0 | $0 | $0 | $0 |
| Net Cash from Investing | $0 | -$13K | -$124K | -$67K | -$19K | -$374K | -$51K | -$417K | -$28K | -$121K | $0 |
| Financing Activities | |||||||||||
| Debt Repaid | - | - | - | - | - | - | - | - | - | - | -$450K |
| Common Stock Issuance | $27.29M | $4.66M | $4.17M | $0 | $74.68M | $22.56M | $19.29M | $12.03M | $6.07M | $9.17M | $2K |
| Common Stock Repurchases | $0 | $0 | $0 | -$23K | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | -$8K | -$25K | $485K | $0 | $40K | -$12K | $1.56M | $20K | $3.99M | -$61 | $0 |
| Net Cash from Financing | $27.28M | $4.63M | $4.65M | -$23K | $74.72M | $22.55M | $20.85M | $12.04M | $10.06M | $8.87M | $452K |
| Forex Effect | $51K | -$32K | -$21K | -$29K | -$24K | $34K | -$4K | -$5K | $0 | $0 | $0 |
| Net Change in Cash | $4.6M | -$19.27M | -$19.59M | -$27.76M | $55.73M | $4.44M | $3.6M | -$580K | $2.71M | $4.98M | $28K |
| Supplementary Data | |||||||||||
| Operating Cash Flow | -$22.73M | -$23.86M | -$24.1M | -$27.64M | -$18.95M | -$17.77M | -$17.2M | -$12.2M | -$7.32M | -$3.76M | -$424K |
| Capital Expenditure | $0 | -$13K | -$124K | -$67K | -$19K | -$376K | -$52K | -$417K | -$28K | -$21K | $0 |
| Free Cash Flow | -$22.73M | -$23.88M | -$24.23M | -$27.71M | -$18.97M | -$18.15M | -$17.25M | -$12.62M | -$7.35M | -$3.79M | -$424K |
| Cash at Beginning | $4.28M | $23.55M | $43.15M | $70.9M | $15.17M | $10.73M | $7.13M | $7.71M | $5.01M | $28K | $0 |
| Cash at End | $8.88M | $4.28M | $23.55M | $43.15M | $70.9M | $15.17M | $10.73M | $7.13M | $7.71M | $5.01M | $28K |